The benefits and risks of Echinacea in treatment of common cold and influenza

Article Sidebar

PDF
Published: Sep 26, 2008
DOI: https://doi.org/10.18051/UnivMed.2008.v27.132-142 Universa Medicina
Abstract Viewed: 776
PDF Downloaded: 227
Keywords:
Echinacea immunomodulation common cold influenza

Main Article Content

Yenny Yenny
Department of Pharmacology, Medical Faculty, Trisakti University
Zunilda Djanun
Department of Pharmacology Faculty of Medicine, University of Indonesia

Abstract

The common cold is one of the world’s most prevalent illnesses in adults and children. This upper respiratory tract infection is caused by different kinds of agents. Effects on health, well-being, and productivity are significant. Preparations made from plants of the genus Echinacea are widely used for the prevention and treatment of colds. Three species of Echinacea used for medicinal purposes are Echinacea purpurea, Echinacea angustifolia, and Echinacea pallida. The beneficial effects of Echinacea are thought to be due to its immunomodulatory activity, most notably activation of macrophages, polymorphonuclear leukocytes and natural killer cells. Many clinical trials, including a number of blind randomized trials, have reported health benefits. Although these studies show beneficial effects, recommendations on Echinacea use cannot be made due to lack of product standardization and variability in dosage, sample size and methodological quality used in the trials. Therefore, well-designed studies with consistent standardized measures are required for assessment of the efficacy of Echinacea in treatment of common cold and influenza.

Article Details

How to Cite
Yenny, Y., & Djanun, Z. (2008). The benefits and risks of Echinacea in treatment of common cold and influenza. Universa Medicina, 27(3), 132–142. https://doi.org/10.18051/UnivMed.2008.v27.132-142
Issue
Vol. 27 No. 3 (2008)
Section
Review Article

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

References

Roxas M, Jurenka J. Cold and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Alter Med Rev 2007; 12: 25-48.

Frederick AM, Monto AS, Nightingale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infections in the United States. Arch Intern Med 2003; 163: 487-94.

Kelly JP, Kaufman DW, Kelly K, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch Intern Med 2005; 165: 281-6.

Blumenthal. Herb sales down in mainstream market, up in natual food stores. Herbal Gram 2002; 55: 60.

Simasek M, Blandino DA. Treatment of the common cold. Am Fam Physician 2007; 75:515-20.

Rajnik M, Murray C, Hospenthal DR. Rhinoviruses. Available at: http://www.emedicine.com/MED/topic2030.htm. Accessed October 15, 2007.

Marcy SM. General information and practitioner guidelines for otitis media. APUA Newsletter 1999. Available at: http://www.tufts.edu/med/apua/PractitionersAOMguidelines.html Accessed October 15, 2007.

Klinger B. Echinacea. Am Fam Physician 2003; 67: 77-80.

National Center for Complementary and Alternative MedicineEchinacea. Herbs at a glance. NCCAM publication. 2005. Available at: http://www.nccam.nih.gov/health/echinacea. Accessed October 15, 2007.

Mills S, Bone K. Principle and practice of phytotherapy: modern herbal medicine. London: Churchil Livingstone; 2000.

Blumenthal M, Gruenwald J, Hall T, Riggins C, Rister R, Kle S. German commission E monograph: medicinal plants for human use. Austin, Texas: American Botanical Council; 1998.

Gruenwald J, Brendler T, Jaenicke C. PDR for nonprescription drugs, dietary supplements, and herbs: the definitive guide to OTC medications. 27th ed. Montvale: Thomson; 2006.

Anonymous. Echinacea: cold comfort. Consumer Rep 2004; 69: 30-3.

Parnham M. Benefits and risks of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulant therapy. Immunomodulatory agents from plants. Boston: Birkhauser Verlag; 1999.

Taylor JA, Weber W, Standish L, Quinn H, Goesling J, McGann M. Efficacy and safety of Echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA 2003; 290: 2824-30.

Mullins RJ, Heddle R. Adverse reactions associated with Echinacea: the Australian experience Ann Allergy Asthma Immunol 2002; 88: 42-51.

Gallo M, Sarkar M, Waisze A, Peterzak K, Comas B, Smith M, et al. Pregnancy outcome following gestational exposure to Echinacea: a prospective controlled study. Arch Intern Med 2000; 160: 3141-3.

Perri D, Dugoua JJ, Mills E, Koren G. Safety and efficacy of Echinacea (Echinacea angustifolia, E. purpurea, and E pallida) during pregnancy and lactation. Can J Clin Pharmacol 2006; 13: e262-7.

Pellati F, Benvenuti S, Margo L. Analysis of phenolic compounds and radical scavenging activity of Echinacea. J Pharm Biomed Anal 2003; 35: 289-301.

Rininger JA, Kickner S, Chigurupati P, McLean A, Franck Z. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J Leukoc Biol 2000; 68: 503-10.

McCann, Solco A, Liu Y, Macaluso F, Murphy PA, Kohut ML. Cytokine and interferon-modulating properties of Echinacea spp root tincture stored at -20°C for 2 years. J Interferon Cytokine Res 2007; 27: 425-36.

Barrett B. Medicinal properties of Echinacea: a critical review. Phytomedicine 2003; 10: 66-86.

Schulten B, Bulitta M, Ballering-Bruhl B, Kostler U, Schafer M. Efficacy of Echinacea purpurea in patients with common cold: a placebo-controlled, randomized, double-blind clinical trial. Arzneimittelforschung 2001; 51: 563-68.

Goel V, Lovlin R, Barton R, Lyon MR, Bauer, Lee TD. Efficacy of a standardized Echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther 2004; 29: 75-83.

Goel V, Lovlin R, Chang C, Slama JV, Barton R, Gahler R, et al. A proprietary extract from the Echinacea plant (Echinacea purpurea) enhances systemic immune respone during common cold. Phytother Res 2005; 19: 689-94.

Cohen H, Varsano I, Kahan E. Effectiveness of an herbal preparation containing Echinacea, Propolis, and vitamin C in preventing respiratory tract infections in children. Arch Pediatr Adolesc Med 2004; 158: 217-21.

Schoop R, Klein P, Suter A, Johnston SL. Echinacea in the prevention of induced rhinovirus cold: a meta analysis. Clin Ther 2006; 28: 174-83.

Barrett BP, Brown RL, Locken K, Maberry R, Bobula JA, D’Alessio D, et al. Treatment of the common cold with unrefined Echinacea: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2002; 137: 939-46.

Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2004; 164: 1237-41.

Sperber S, Shah L, Gilbert R. Echinacea purpurea for prevention of experimental rhinovirus colds. Clin Infect Dis 2004; 38: 1367-71.

Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi D. An evaluation of Echinacea angustifolia in experimental rhinovirus infection. N Engl J Med 2005; 354: 341-8.

Linda K, Barrett B, Wolkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold (Review). Cochrane database of systematic review 2006, Issue 1. Art No.: CD000530. DOI: 10.1002/14651858.CD000530.pub2.